KETOCONAZOLE

KETOCONAZOLE was reported 17636 times

KETOCONAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PURPURA SENILE 13 0.1066
1 SEBORRHOEIC DERMATITIS 99 0.0599
2 TARSAL TUNNEL SYNDROME 13 0.0591
3 INTERTRIGO 29 0.0532
4 CORTISOL INCREASED 31 0.0496
5 ASPERGILLUS TEST POSITIVE 15 0.0487
6 TOXIC SHOCK SYNDROME 25 0.0397
7 TINEA VERSICOLOUR 14 0.0389
8 DANDRUFF 82 0.0370
9 BODY TINEA 19 0.0339
10 ENDOCRINE OPHTHALMOPATHY 28 0.0323
11 TENOSYNOVITIS STENOSANS 17 0.0305
12 LENTIGO 14 0.0282
13 TINEA CRURIS 13 0.0261
14 SEBORRHOEIC KERATOSIS 34 0.0234
15 OTITIS MEDIA ACUTE 16 0.0217
16 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23 0.0217
17 HYPERPARATHYROIDISM SECONDARY 52 0.0207
18 NEPHROGENIC ANAEMIA 96 0.0207
19 NASAL ULCER 29 0.0182
20 XEROSIS 22 0.0178
21 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 16 0.0173
22 TINEA PEDIS 27 0.0169
23 PNEUMONIA MYCOPLASMAL 13 0.0163
24 ARTHRODESIS 16 0.0157
25 MEAN CELL HAEMOGLOBIN INCREASED 25 0.0151
26 IMPETIGO 22 0.0148
27 TRICHORRHEXIS 41 0.0147
28 EYELID DISORDER 33 0.0143
29 JAW FRACTURE 30 0.0139
30 HAIR TEXTURE ABNORMAL 185 0.0138
31 VESTIBULAR DISORDER 15 0.0122
32 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 32 0.0120
33 CONTRAINDICATION TO MEDICAL TREATMENT 18 0.0118
34 VERTIGO POSITIONAL 20 0.0114
35 PULMONARY GRANULOMA 13 0.0114
36 BONE DEMINERALISATION 12 0.0113
37 ACTINIC KERATOSIS 29 0.0112
38 PUSTULE 26 0.0110
39 ESSENTIAL HYPERTENSION 20 0.0109
40 REBOUND ACID HYPERSECRETION 32 0.0106
41 FUNGAL SKIN INFECTION 41 0.0101
42 PAPULE 64 0.0091
43 OBSTRUCTIVE SLEEP APNOEA SYNDROME 13 0.0089
44 PRODUCT ADMINISTRATION INTERRUPTED 69 0.0088
45 OTITIS MEDIA 29 0.0088
46 END STAGE RENAL DISEASE 153 0.0084
47 SUSPECTED COUNTERFEIT PRODUCT 32 0.0081
48 SKIN WEEPING 28 0.0078
49 DYSLIPIDAEMIA 39 0.0077
50 DEAFNESS BILATERAL 13 0.0076
51 SEBORRHOEA 28 0.0076
52 SWELLING OF EYELID 47 0.0075
53 PROSTATE CANCER METASTATIC 25 0.0075
54 SKIN PAPILLOMA 30 0.0075
55 AORTIC ARTERIOSCLEROSIS 19 0.0074
56 CRYPTOCOCCOSIS 12 0.0074
57 SYNOVIAL CYST 34 0.0074
58 DERMATITIS PSORIASIFORM 15 0.0073
59 MELANOCYTIC NAEVUS 32 0.0073
60 ECONOMIC PROBLEM 110 0.0073
61 CHEST X-RAY ABNORMAL 22 0.0072
62 SKIN PLAQUE 59 0.0070
63 ADRENAL INSUFFICIENCY 84 0.0069
64 CHRONIC KIDNEY DISEASE 521 0.0069
65 RHINITIS ALLERGIC 30 0.0067
66 ADRENOCORTICAL INSUFFICIENCY ACUTE 13 0.0067
67 BLOOD IMMUNOGLOBULIN E INCREASED 16 0.0066
68 HAIR COLOUR CHANGES 82 0.0066
69 ROSACEA 30 0.0064
70 CLOSTRIDIUM TEST POSITIVE 14 0.0063
71 PRE-EXISTING CONDITION IMPROVED 39 0.0062
72 BLOOD CHLORIDE DECREASED 16 0.0062
73 ANHEDONIA 162 0.0062
74 MACULE 17 0.0061
75 THROMBOPHLEBITIS SUPERFICIAL 18 0.0059
76 PROSTATIC SPECIFIC ANTIGEN INCREASED 81 0.0059
77 LUMBAR SPINAL STENOSIS 17 0.0058
78 BENIGN PROSTATIC HYPERPLASIA 30 0.0058
79 LUNG CONSOLIDATION 16 0.0057
80 SKIN HYPERTROPHY 16 0.0057
81 SCAB 64 0.0056
82 LOOSE TOOTH 18 0.0056
83 PRURITUS GENITAL 13 0.0055
84 HYPERCHOLESTEROLAEMIA 52 0.0054
85 BACTERIAL TEST POSITIVE 12 0.0054
86 MIXED LIVER INJURY 16 0.0053
87 DERMAL CYST 13 0.0053
88 SPINAL OSTEOARTHRITIS 46 0.0052
89 LIP PAIN 15 0.0052
90 MYCOBACTERIUM AVIUM COMPLEX INFECTION 14 0.0052
91 DERMATITIS 107 0.0051
92 PSORIASIS 663 0.0051
93 BONE LESION 18 0.0050
94 HYPERLIPIDAEMIA 59 0.0049
95 SKIN LACERATION 53 0.0049
96 PRODUCT LABEL ISSUE 33 0.0049
97 SLEEP APNOEA SYNDROME 92 0.0048
98 DIVERTICULUM 34 0.0048
99 VITAMIN D DECREASED 40 0.0047
100 HYPERTRIGLYCERIDAEMIA 27 0.0046
101 LEG AMPUTATION 19 0.0046
102 ONYCHOMYCOSIS 20 0.0046
103 HYPERKERATOSIS 25 0.0045
104 HERPES VIRUS INFECTION 26 0.0045
105 HEPATITIS FULMINANT 13 0.0044
106 EYE INFECTION 48 0.0042
107 ISCHAEMIC CARDIOMYOPATHY 13 0.0042
108 SKIN INFECTION 47 0.0042
109 SKIN EXFOLIATION 353 0.0042
110 METASTASES TO SPINE 14 0.0042
111 BLOOD CREATININE DECREASED 13 0.0041
112 THERAPEUTIC PRODUCT INEFFECTIVE 16 0.0041
113 APPLICATION SITE DRYNESS 14 0.0041
114 OSTEOPENIA 62 0.0041
115 GINGIVITIS 22 0.0041
116 RENAL CYST 32 0.0040
117 SPUTUM DISCOLOURED 38 0.0040
118 CHRONIC SINUSITIS 15 0.0040
119 SKIN HYPERPIGMENTATION 34 0.0040
120 FUNGAL INFECTION 130 0.0039
121 SKIN DISORDER 130 0.0039
122 DIVERTICULUM INTESTINAL 17 0.0039
123 DIASTOLIC DYSFUNCTION 12 0.0039
124 HAIR DISORDER 32 0.0039
125 PROSTATOMEGALY 15 0.0038
126 SKIN ABRASION 18 0.0038
127 FOOT DEFORMITY 42 0.0038
128 DERMATITIS CONTACT 43 0.0038
129 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64 0.0038
130 DERMATITIS ATOPIC 198 0.0038
131 VITAMIN D DEFICIENCY 36 0.0037
132 RENAL TUBULAR NECROSIS 36 0.0037
133 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 200 0.0036
134 DIABETIC NEUROPATHY 18 0.0036
135 ARTERIOSCLEROSIS CORONARY ARTERY 24 0.0036
136 PRODUCT PHYSICAL CONSISTENCY ISSUE 20 0.0036
137 PIGMENTATION DISORDER 22 0.0036
138 SUBCUTANEOUS ABSCESS 17 0.0035
139 MUSCLE FATIGUE 15 0.0035
140 BLOOD TESTOSTERONE DECREASED 24 0.0035
141 SKIN HAEMORRHAGE 52 0.0035
142 SKIN LESION 96 0.0035
143 APPLICATION SITE PAIN 77 0.0035
144 SEASONAL ALLERGY 49 0.0035
145 INTERVERTEBRAL DISC DEGENERATION 32 0.0035
146 SPINAL FUSION SURGERY 14 0.0034
147 SKIN MASS 23 0.0034
148 ATELECTASIS 33 0.0034
149 SKIN IRRITATION 156 0.0034
150 SKIN ULCER 88 0.0034
151 RENAL FAILURE CHRONIC 26 0.0034
152 PERIORBITAL SWELLING 19 0.0034
153 SINUS DISORDER 66 0.0033
154 PERIPHERAL VASCULAR DISORDER 17 0.0033
155 JAW DISORDER 18 0.0033
156 ABSCESS LIMB 14 0.0033
157 PURULENT DISCHARGE 14 0.0033
158 PSORIATIC ARTHROPATHY 133 0.0033
159 FAILURE TO THRIVE 17 0.0033
160 TRICUSPID VALVE INCOMPETENCE 26 0.0033
161 OESOPHAGEAL CANDIDIASIS 13 0.0033
162 RENAL FAILURE 430 0.0032
163 CARDIAC MURMUR 28 0.0032
164 IMPAIRED GASTRIC EMPTYING 44 0.0032
165 BRADYKINESIA 19 0.0032
166 ECZEMA 168 0.0032
167 APPLICATION SITE SWELLING 16 0.0032
168 ARTERIOSCLEROSIS 30 0.0032
169 HIDRADENITIS 29 0.0032
170 TENDERNESS 33 0.0032
171 UPPER-AIRWAY COUGH SYNDROME 26 0.0032
172 DERMATITIS ACNEIFORM 19 0.0031
173 NAIL DISORDER 27 0.0031
174 APPLICATION SITE PRURITUS 70 0.0031
175 CONTRAINDICATED PRODUCT ADMINISTERED 93 0.0031
176 SKIN FISSURES 60 0.0031
177 SCOLIOSIS 19 0.0031
178 MULTIPLE ALLERGIES 24 0.0031
179 AFFECTIVE DISORDER 24 0.0030
180 LEFT VENTRICULAR HYPERTROPHY 13 0.0030
181 NEPHROPATHY 28 0.0030
182 ERECTILE DYSFUNCTION 77 0.0030
183 NOCTURIA 36 0.0030
184 HEPATOTOXICITY 66 0.0030
185 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 210 0.0029
186 SCRATCH 31 0.0029
187 HAEMORRHOIDS 57 0.0029
188 APPLICATION SITE EXFOLIATION 12 0.0029
189 FURUNCLE 23 0.0029
190 SKIN SWELLING 25 0.0029
191 OSTEOARTHRITIS 121 0.0029
192 ELECTROLYTE IMBALANCE 33 0.0028
193 THERAPEUTIC RESPONSE UNEXPECTED 127 0.0028
194 HYPOKALAEMIA 130 0.0028
195 BONE DISORDER 51 0.0028
196 PERFORMANCE STATUS DECREASED 13 0.0028
197 PRODUCT RESIDUE PRESENT 15 0.0028
198 DRY SKIN 371 0.0028
199 YELLOW SKIN 13 0.0028
200 ECCHYMOSIS 19 0.0028
201 FULL BLOOD COUNT ABNORMAL 29 0.0027
202 DENTAL CARIES 30 0.0027
203 MULTIPLE INJURIES 17 0.0027
204 DECUBITUS ULCER 22 0.0027
205 FOLLICULITIS 28 0.0027
206 NEUTROPENIC SEPSIS 19 0.0027
207 CELLULITIS 134 0.0027
208 TOOTH INFECTION 35 0.0027
209 PRURITUS 1020 0.0027
210 JOINT EFFUSION 18 0.0026
211 NERVE INJURY 29 0.0026
212 HAIR GROWTH ABNORMAL 18 0.0026
213 MAJOR DEPRESSION 19 0.0026
214 BRUXISM 14 0.0026
215 ORAL DISORDER 19 0.0026
216 DRUG INTERACTION 410 0.0026
217 ORTHOSTATIC HYPOTENSION 45 0.0026
218 APPLICATION SITE IRRITATION 32 0.0026
219 HYPOPHOSPHATAEMIA 19 0.0026
220 THERAPY PARTIAL RESPONDER 40 0.0026
221 MITRAL VALVE INCOMPETENCE 29 0.0026
222 METASTASES TO BONE 42 0.0026
223 ACUTE KIDNEY INJURY 391 0.0026
224 HAND FRACTURE 18 0.0025
225 OSTEOMYELITIS 46 0.0025
226 HYDRONEPHROSIS 19 0.0025
227 NODULE 33 0.0025
228 RHABDOMYOLYSIS 105 0.0025
229 EYE DISCHARGE 26 0.0025
230 RENAL INJURY 74 0.0025
231 LUNG INFILTRATION 22 0.0025
232 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 22 0.0025
233 URINARY INCONTINENCE 73 0.0025
234 BLOOD ALKALINE PHOSPHATASE INCREASED 61 0.0025
235 TUBULOINTERSTITIAL NEPHRITIS 46 0.0025
236 OBESITY 39 0.0024
237 MENISCUS INJURY 15 0.0024
238 ALOPECIA 478 0.0024
239 ARTHROPOD BITE 18 0.0024
240 COMPRESSION FRACTURE 13 0.0024
241 PRODUCT USE IN UNAPPROVED INDICATION 600 0.0024
242 DECREASED ACTIVITY 26 0.0024
243 BONE DENSITY DECREASED 75 0.0024
244 BREAST MASS 16 0.0024
245 GLUCOSE TOLERANCE IMPAIRED 14 0.0024
246 PROTHROMBIN TIME PROLONGED 14 0.0023
247 PAIN OF SKIN 63 0.0023
248 FOOD ALLERGY 18 0.0023
249 ONYCHOCLASIS 16 0.0023
250 THERAPEUTIC RESPONSE SHORTENED 77 0.0023
251 LYMPHOEDEMA 16 0.0023
252 LARGE INTESTINE POLYP 16 0.0023
253 BASAL CELL CARCINOMA 36 0.0023
254 SENSITIVE SKIN 17 0.0023
255 EXOSTOSIS 21 0.0023
256 APPLICATION SITE ERYTHEMA 60 0.0023
257 PULMONARY MASS 34 0.0023
258 INCREASED TENDENCY TO BRUISE 21 0.0023
259 CARDIOMEGALY 28 0.0023
260 FEEDING DISORDER 46 0.0023
261 TOOTH ABSCESS 23 0.0023
262 ROTATOR CUFF SYNDROME 29 0.0023
263 PHARYNGITIS 28 0.0023
264 ATRIAL FLUTTER 18 0.0023
265 THERMAL BURN 16 0.0023
266 INFUSION SITE EXTRAVASATION 14 0.0022
267 OBSESSIVE-COMPULSIVE DISORDER 18 0.0022
268 RALES 13 0.0022
269 POST-TRAUMATIC STRESS DISORDER 15 0.0022
270 HOSPICE CARE 22 0.0022
271 EOSINOPHILIA 39 0.0022
272 INFUSION SITE SWELLING 14 0.0022
273 PSEUDOMONAS INFECTION 19 0.0022
274 PELVIC PAIN 40 0.0022
275 ANKLE FRACTURE 34 0.0022
276 CYST 27 0.0022
277 BLOOD SODIUM DECREASED 41 0.0022
278 BRAIN FOG 34 0.0022
279 OSTEOPOROSIS 89 0.0022
280 HIATUS HERNIA 28 0.0022
281 CONJUNCTIVITIS 40 0.0022
282 RASH ERYTHEMATOUS 103 0.0022
283 BACTERIAL INFECTION 40 0.0021
284 INFUSION SITE ERYTHEMA 18 0.0021
285 PRODUCT FORMULATION ISSUE 14 0.0021
286 FOOT FRACTURE 40 0.0021
287 SCAR 36 0.0021
288 GASTROOESOPHAGEAL REFLUX DISEASE 169 0.0021
289 PNEUMOCYSTIS JIROVECII PNEUMONIA 21 0.0021
290 RIB FRACTURE 43 0.0021
291 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 109 0.0021
292 PATHOGEN RESISTANCE 19 0.0021
293 HEPATITIS 53 0.0021
294 HICCUPS 17 0.0021
295 SINUS BRADYCARDIA 20 0.0021
296 LOW DENSITY LIPOPROTEIN INCREASED 16 0.0021
297 CONCUSSION 16 0.0021
298 RASH PUSTULAR 15 0.0021
299 SLUGGISHNESS 21 0.0021
300 SURGERY 120 0.0020
301 TOOTHACHE 37 0.0020
302 RASH MACULAR 71 0.0020
303 SKIN DISCOLOURATION 93 0.0020
304 LIGAMENT SPRAIN 20 0.0020
305 VENTRICULAR EXTRASYSTOLES 21 0.0020
306 HAEMATOCRIT DECREASED 40 0.0020
307 MICTURITION URGENCY 23 0.0020
308 QUALITY OF LIFE DECREASED 27 0.0020
309 RASH PRURITIC 109 0.0020
310 RASH 874 0.0020
311 APPLICATION SITE VESICLES 13 0.0020
312 DRY EYE 100 0.0020
313 PHOTOSENSITIVITY REACTION 33 0.0020
314 SENSORY DISTURBANCE 32 0.0020
315 CHROMATURIA 45 0.0020
316 RED BLOOD CELL SEDIMENTATION RATE INCREASED 22 0.0020
317 LOCALISED INFECTION 48 0.0020
318 SUPRAVENTRICULAR TACHYCARDIA 19 0.0020
319 AORTIC ANEURYSM 15 0.0020
320 BURNING SENSATION 138 0.0020
321 INTERVERTEBRAL DISC PROTRUSION 43 0.0020
322 INTENTIONAL DOSE OMISSION 56 0.0020
323 PERIPHERAL SWELLING 302 0.0020
324 IRRITABLE BOWEL SYNDROME 42 0.0020
325 BOWEL MOVEMENT IRREGULARITY 15 0.0020
326 EAR INFECTION 52 0.0020
327 IRON DEFICIENCY ANAEMIA 18 0.0019
328 ERYTHEMA 400 0.0019
329 ATRIOVENTRICULAR BLOCK COMPLETE 13 0.0019
330 OSTEONECROSIS OF JAW 48 0.0019
331 VITREOUS FLOATERS 19 0.0019
332 BRONCHIECTASIS 13 0.0019
333 RENAL FAILURE ACUTE 81 0.0019
334 TREATMENT FAILURE 158 0.0019
335 ABNORMAL LOSS OF WEIGHT 13 0.0019
336 TOOTH FRACTURE 21 0.0019
337 DRUG EFFECT LESS THAN EXPECTED 28 0.0019
338 GINGIVAL PAIN 15 0.0019
339 HYPERKALAEMIA 66 0.0019
340 ARTHRITIS 148 0.0019
341 EYE PRURITUS 63 0.0019
342 FORMICATION 13 0.0019
343 BLOOD CHOLESTEROL INCREASED 87 0.0019
344 MUSCULOSKELETAL DISCOMFORT 32 0.0019
345 LIVER FUNCTION TEST ABNORMAL 54 0.0019
346 GAIT INABILITY 62 0.0019
347 PNEUMONIA BACTERIAL 17 0.0019
348 EAR DISCOMFORT 19 0.0018
349 SINUS CONGESTION 25 0.0018
350 HYPOTHYROIDISM 59 0.0018
351 AUTOIMMUNE DISORDER 18 0.0018
352 THERAPY NON-RESPONDER 83 0.0018
353 ORAL HERPES 36 0.0018
354 BIPOLAR DISORDER 20 0.0018
355 URINARY TRACT INFECTION 311 0.0018
356 SCIATICA 29 0.0018
357 UPPER RESPIRATORY TRACT INFECTION 84 0.0018
358 PRODUCT ODOUR ABNORMAL 19 0.0018
359 POOR QUALITY SLEEP 39 0.0018
360 APPETITE DISORDER 12 0.0018
361 DYSPNOEA EXERTIONAL 68 0.0018
362 MOUTH ULCERATION 38 0.0018
363 HYPOALBUMINAEMIA 14 0.0018
364 EAR PAIN 35 0.0018
365 BONE LOSS 27 0.0018
366 BLOOD POTASSIUM DECREASED 54 0.0018
367 CYSTITIS 57 0.0018
368 PRODUCT PACKAGING ISSUE 17 0.0018
369 NEPHROLITHIASIS 82 0.0018
370 BLOOD POTASSIUM INCREASED 29 0.0018
371 ELECTROCARDIOGRAM ABNORMAL 14 0.0018
372 SYNOVITIS 32 0.0018
373 ASPARTATE AMINOTRANSFERASE INCREASED 94 0.0018
374 GLAUCOMA 34 0.0018
375 LIP DRY 16 0.0018
376 HEPATIC CIRRHOSIS 33 0.0018
377 TOOTH DISORDER 39 0.0018
378 FEELING DRUNK 13 0.0017
379 SUNBURN 13 0.0017
380 COAGULOPATHY 29 0.0017
381 BLOOD MAGNESIUM DECREASED 15 0.0017
382 OSTEONECROSIS 57 0.0017
383 EMOTIONAL DISTRESS 210 0.0017
384 OEDEMA 94 0.0017
385 LIMB INJURY 47 0.0017
386 BRONCHITIS 128 0.0017
387 NEURALGIA 42 0.0017
388 BLISTER 97 0.0017
389 PETECHIAE 18 0.0017
390 ACUTE RESPIRATORY FAILURE 33 0.0017
391 GASTROENTERITIS 25 0.0017
392 HYPERSOMNIA 49 0.0017
393 INFUSION SITE PAIN 22 0.0017
394 SMALL INTESTINAL OBSTRUCTION 21 0.0017
395 EYE IRRITATION 98 0.0017
396 OVARIAN CYST 17 0.0017
397 COVID-19 PNEUMONIA 20 0.0017
398 ANXIETY 481 0.0017
399 OCULAR HYPERAEMIA 80 0.0017
400 EMPHYSEMA 17 0.0017
401 CORONARY ARTERY DISEASE 51 0.0017
402 EYE PAIN 95 0.0017
403 BODY HEIGHT DECREASED 18 0.0017
404 EOSINOPHIL COUNT INCREASED 14 0.0017
405 CHOLELITHIASIS 55 0.0017
406 SECRETION DISCHARGE 21 0.0017
407 HALLUCINATION 126 0.0017
408 MUSCULAR WEAKNESS 190 0.0017
409 MYOSITIS 15 0.0017
410 BLOOD CREATININE INCREASED 109 0.0017
411 NEUROPATHY PERIPHERAL 158 0.0017
412 CANDIDA INFECTION 28 0.0017
413 DRUG-INDUCED LIVER INJURY 52 0.0017
414 INITIAL INSOMNIA 17 0.0017
415 MENTAL STATUS CHANGES 46 0.0017
416 RASH PAPULAR 37 0.0016
417 DIZZINESS POSTURAL 16 0.0016
418 RESTLESS LEGS SYNDROME 30 0.0016
419 BURSITIS 20 0.0016
420 OESOPHAGITIS 18 0.0016
421 HYPOXIA 58 0.0016
422 DRUG EXPOSURE DURING PREGNANCY 56 0.0016
423 ALANINE AMINOTRANSFERASE INCREASED 101 0.0016
424 CARPAL TUNNEL SYNDROME 23 0.0016
425 PNEUMONIA ASPIRATION 41 0.0016
426 STAPHYLOCOCCAL INFECTION 54 0.0016
427 ADVERSE DRUG REACTION 147 0.0016
428 VASCULITIS 19 0.0016
429 DYSURIA 60 0.0016
430 UROSEPSIS 15 0.0016
431 NERVE COMPRESSION 15 0.0016
432 WEIGHT FLUCTUATION 17 0.0016
433 CARDIOMYOPATHY 24 0.0016
434 CONDITION AGGRAVATED 493 0.0016
435 PRODUCT DISTRIBUTION ISSUE 15 0.0016
436 GENERALISED OEDEMA 20 0.0016
437 SENSORY LOSS 13 0.0016
438 PRODUCTIVE COUGH 77 0.0016
439 HEPATIC STEATOSIS 30 0.0016
440 MALNUTRITION 18 0.0016
441 DEAFNESS 42 0.0016
442 HAEMATURIA 55 0.0016
443 DYSTONIA 31 0.0016
444 SWELLING FACE 104 0.0016
445 PHOTOPHOBIA 30 0.0016
446 ORAL CANDIDIASIS 21 0.0016
447 SINUSITIS 163 0.0016
448 DERMATITIS ALLERGIC 20 0.0016
449 DEPRESSION 361 0.0016
450 SPINAL DISORDER 15 0.0016
451 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35 0.0016
452 MASS 22 0.0016
453 TRANSAMINASES INCREASED 35 0.0016
454 SPINAL COMPRESSION FRACTURE 13 0.0016
455 DRUG LEVEL INCREASED 26 0.0016
456 ABSCESS 25 0.0016
457 NEOPLASM 18 0.0016
458 DYSPEPSIA 154 0.0016
459 PAIN IN JAW 44 0.0016
460 NIGHT SWEATS 50 0.0016
461 TEMPERATURE INTOLERANCE 16 0.0015
462 ARTHROPATHY 86 0.0015
463 TOOTH LOSS 32 0.0015
464 SPINAL OPERATION 19 0.0015
465 LIVER FUNCTION TEST INCREASED 33 0.0015
466 SPLENOMEGALY 18 0.0015
467 SPINAL PAIN 18 0.0015
468 SEXUAL DYSFUNCTION 18 0.0015
469 POLLAKIURIA 64 0.0015
470 PHARYNGEAL SWELLING 15 0.0015
471 ILEUS 19 0.0015
472 ACUTE MYOCARDIAL INFARCTION 45 0.0015
473 PROTEINURIA 29 0.0015
474 JAUNDICE 41 0.0015
475 LACRIMATION INCREASED 46 0.0015
476 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 73 0.0015
477 CARDIAC FAILURE CONGESTIVE 122 0.0015
478 ORAL PAIN 34 0.0015
479 GASTROINTESTINAL DISORDER 136 0.0015
480 SLEEP DISORDER 107 0.0015
481 PNEUMOTHORAX 24 0.0015
482 MIGRAINE 144 0.0015
483 PSYCHOLOGICAL TRAUMA 13 0.0015
484 WOUND 42 0.0015
485 ELECTROCARDIOGRAM QT PROLONGED 54 0.0015
486 SALIVARY HYPERSECRETION 15 0.0015
487 URINARY RETENTION 50 0.0015
488 SKIN BURNING SENSATION 107 0.0015
489 FLANK PAIN 14 0.0015
490 LACERATION 14 0.0015
491 SQUAMOUS CELL CARCINOMA 14 0.0015
492 GASTRITIS 39 0.0015
493 BLOOD BILIRUBIN INCREASED 40 0.0015
494 DELUSION 23 0.0015
495 SINUS TACHYCARDIA 21 0.0015
496 ANOREXIA 19 0.0015
497 DYSPHONIA 86 0.0015
498 ABNORMAL FAECES 12 0.0015
499 FLATULENCE 83 0.0015
500 HYPOAESTHESIA ORAL 22 0.0015
501 CHOLESTASIS 28 0.0015
502 FACIAL PAIN 13 0.0015
503 LIMB DISCOMFORT 45 0.0015
504 OEDEMA PERIPHERAL 177 0.0015
505 BACK PAIN 337 0.0014
506 TOXIC EPIDERMAL NECROLYSIS 22 0.0014
507 OFF LABEL USE 1268 0.0014
508 SEPTIC SHOCK 63 0.0014
509 HALLUCINATION, AUDITORY 23 0.0014
510 HYPOPHAGIA 37 0.0014
511 ANAL INCONTINENCE 13 0.0014
512 WEIGHT DECREASED 403 0.0014
513 DRY MOUTH 117 0.0014
514 BALANCE DISORDER 124 0.0014
515 COORDINATION ABNORMAL 20 0.0014
516 EYE DISORDER 47 0.0014
517 NASAL CONGESTION 84 0.0014
518 C-REACTIVE PROTEIN INCREASED 52 0.0014
519 THYROID DISORDER 22 0.0014
520 ARTHRALGIA 593 0.0014
521 PRODUCT DOSE OMISSION 93 0.0014
522 HEPATOMEGALY 14 0.0014
523 ACNE 108 0.0014
524 RHINORRHOEA 92 0.0014
525 HALLUCINATION, VISUAL 30 0.0014
526 HOT FLUSH 107 0.0014
527 JOINT DISLOCATION 15 0.0014
528 DISABILITY 28 0.0014
529 PRODUCT USE ISSUE 266 0.0014
530 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
531 PRODUCT DOSE OMISSION ISSUE 415 0.0014
532 HERPES ZOSTER 81 0.0014
533 BLOOD PRESSURE ABNORMAL 28 0.0014
534 FIBROMYALGIA 34 0.0014
535 CONSTIPATION 305 0.0014
536 ASTHMA 158 0.0014
537 MUSCLE SPASMS 256 0.0014
538 NO THERAPEUTIC RESPONSE 17 0.0014
539 TINNITUS 64 0.0014
540 VENTRICULAR TACHYCARDIA 23 0.0014
541 CONTUSION 133 0.0014
542 PLATELET COUNT INCREASED 18 0.0014
543 TREMOR 229 0.0014
544 DEHYDRATION 184 0.0014
545 BACK INJURY 15 0.0014
546 FALL 459 0.0014
547 INSURANCE ISSUE 21 0.0014
548 INTERNATIONAL NORMALISED RATIO INCREASED 39 0.0014
549 NEUTROPHIL COUNT INCREASED 14 0.0014
550 PHARYNGEAL OEDEMA 21 0.0014
551 CATARACT 81 0.0014
552 HEPATIC FAILURE 41 0.0014
553 NECK PAIN 76 0.0014
554 ACUTE RESPIRATORY DISTRESS SYNDROME 24 0.0014
555 BACK DISORDER 22 0.0014
556 THERAPEUTIC RESPONSE DECREASED 82 0.0014
557 OXYGEN SATURATION DECREASED 76 0.0014
558 DRUG INEFFECTIVE 1779 0.0013
559 BLOOD IRON DECREASED 16 0.0013
560 ANAEMIA 257 0.0013
561 GALLBLADDER DISORDER 24 0.0013
562 CHOLECYSTITIS 16 0.0013
563 PRODUCT DOSE OMISSION IN ERROR 38 0.0013
564 OROPHARYNGEAL PAIN 124 0.0013
565 GOUT 24 0.0013
566 OCULAR DISCOMFORT 15 0.0013
567 WRIST FRACTURE 16 0.0013
568 TRANSIENT ISCHAEMIC ATTACK 45 0.0013
569 PRODUCT USE COMPLAINT 21 0.0013
570 BRONCHOSPASM 19 0.0013
571 INJECTION SITE DISCOMFORT 14 0.0013
572 TASTE DISORDER 27 0.0013
573 COGNITIVE DISORDER 62 0.0013
574 DYSPHAGIA 126 0.0013
575 HEAD INJURY 42 0.0013
576 MYALGIA 225 0.0013
577 ASTHENIA 497 0.0013
578 HEPATIC ENZYME INCREASED 90 0.0013
579 RETCHING 28 0.0013
580 BREAST PAIN 14 0.0013
581 JOINT INJURY 28 0.0013
582 PULMONARY FIBROSIS 25 0.0013
583 ILLNESS 134 0.0013
584 JOINT SWELLING 157 0.0013
585 METASTASES TO LUNG 15 0.0013
586 DIARRHOEA 838 0.0013
587 BRAIN INJURY 13 0.0013
588 PULMONARY HYPERTENSION 27 0.0013
589 JOINT STIFFNESS 34 0.0013
590 HYPERCALCAEMIA 16 0.0013
591 LOSS OF CONSCIOUSNESS 166 0.0013
592 ORAL DISCOMFORT 18 0.0013
593 RED BLOOD CELL COUNT DECREASED 37 0.0013
594 HYPERSENSITIVITY 240 0.0013
595 HYPERGLYCAEMIA 47 0.0013
596 PANIC ATTACK 47 0.0013
597 FATIGUE 1004 0.0013
598 PRODUCT PHYSICAL ISSUE 26 0.0013
599 ERYTHEMA MULTIFORME 12 0.0013
600 LIVER DISORDER 57 0.0013
601 PNEUMONIA 416 0.0013
602 DEFORMITY 12 0.0013
603 HEART RATE IRREGULAR 29 0.0013
604 CLOSTRIDIUM DIFFICILE INFECTION 28 0.0013
605 INJECTION SITE DISCOLOURATION 16 0.0013
606 VERTIGO 78 0.0013
607 DYSKINESIA 52 0.0013
608 SYNCOPE 128 0.0013
609 SKIN REACTION 18 0.0013
610 PRESYNCOPE 31 0.0013
611 IMMUNODEFICIENCY 19 0.0013
612 THERAPEUTIC PRODUCT EFFECT DECREASED 57 0.0013
613 COUGH 356 0.0013
614 MALIGNANT MELANOMA 17 0.0013
615 CHEST PAIN 235 0.0013
616 HAEMATOCHEZIA 70 0.0013
617 DIZZINESS 632 0.0013
618 GAIT DISTURBANCE 242 0.0013
619 SEPSIS 141 0.0013
620 MENTAL DISORDER 55 0.0013
621 GASTRIC ULCER 24 0.0013
622 PAIN IN EXTREMITY 372 0.0013
623 THROMBOCYTOPENIA 141 0.0013
624 DIABETES MELLITUS 96 0.0013
625 INTENTIONAL PRODUCT MISUSE 110 0.0013
626 HYPOAESTHESIA 188 0.0013
627 HEPATIC CYTOLYSIS 16 0.0013
628 IMPAIRED HEALING 41 0.0012
629 SWOLLEN TONGUE 39 0.0012
630 DRUG RESISTANCE 32 0.0012
631 FISTULA 14 0.0012
632 LYMPHOCYTE COUNT DECREASED 22 0.0012
633 LYMPHADENOPATHY 44 0.0012
634 DRUG ERUPTION 22 0.0012
635 FULL BLOOD COUNT DECREASED 25 0.0012
636 REBOUND EFFECT 14 0.0012
637 HYPOGLYCAEMIA 60 0.0012
638 APPLICATION SITE RASH 17 0.0012
639 MUSCLE TIGHTNESS 20 0.0012
640 RECTAL HAEMORRHAGE 53 0.0012
641 EXPIRED PRODUCT ADMINISTERED 41 0.0012
642 DIPLOPIA 32 0.0012
643 WHEEZING 73 0.0012
644 INCONTINENCE 13 0.0012
645 INFECTION 178 0.0012
646 DIVERTICULITIS 34 0.0012
647 PAIN 753 0.0012
648 CHOLECYSTECTOMY 14 0.0012
649 HEADACHE 768 0.0012
650 COELIAC DISEASE 12 0.0012
651 EJECTION FRACTION DECREASED 19 0.0012
652 ATRIAL FIBRILLATION 119 0.0012
653 EATING DISORDER 26 0.0012
654 HUNGER 17 0.0012
655 HAEMOPTYSIS 34 0.0012
656 PARANOIA 21 0.0012
657 SWELLING 114 0.0012
658 BEDRIDDEN 16 0.0012
659 INSOMNIA 324 0.0012
660 BONE PAIN 71 0.0012
661 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
662 COVID-19 212 0.0012
663 TOOTH EXTRACTION 15 0.0012
664 LUNG DISORDER 59 0.0012
665 VIRAL INFECTION 40 0.0012
666 DIALYSIS 17 0.0012
667 HAEMATOMA 31 0.0012
668 BLOOD UREA INCREASED 20 0.0012
669 ULCER 19 0.0012
670 PRODUCT PRESCRIBING ISSUE 26 0.0012
671 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 215 0.0012
672 SUICIDAL IDEATION 109 0.0012
673 UNEVALUABLE EVENT 90 0.0012
674 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
675 TYPE 2 DIABETES MELLITUS 40 0.0012
676 PLEURAL EFFUSION 72 0.0012
677 IMPAIRED QUALITY OF LIFE 17 0.0012
678 INFLAMMATION 61 0.0012
679 HEART RATE INCREASED 117 0.0012
680 HYPERTENSION 249 0.0012
681 THERAPY INTERRUPTED 84 0.0012
682 CHEST DISCOMFORT 120 0.0012
683 COMPLICATION ASSOCIATED WITH DEVICE 17 0.0012
684 INTESTINAL OBSTRUCTION 44 0.0012
685 RENAL IMPAIRMENT 98 0.0012
686 ACTIVITIES OF DAILY LIVING IMPAIRED 23 0.0012
687 LEUKOPENIA 58 0.0012
688 PARAESTHESIA 182 0.0012
689 MULTIPLE FRACTURES 19 0.0012
690 DYSPNOEA 653 0.0012
691 INJURY 81 0.0012
692 ABDOMINAL DISTENSION 120 0.0011
693 HYPOMAGNESAEMIA 16 0.0011
694 ABORTION SPONTANEOUS 46 0.0011
695 THROAT TIGHTNESS 31 0.0011
696 MUSCLE SPASTICITY 14 0.0011
697 DEEP VEIN THROMBOSIS 74 0.0011
698 IMMUNE SYSTEM DISORDER 15 0.0011
699 DRUG ADMINISTERED AT INAPPROPRIATE SITE 12 0.0011
700 INTERNAL HAEMORRHAGE 13 0.0011
701 STOMATITIS 69 0.0011
702 NAUSEA 898 0.0011
703 SEIZURE 131 0.0011
704 LETHARGY 65 0.0011
705 EYE SWELLING 42 0.0011
706 TACHYCARDIA 100 0.0011
707 HEPATIC FUNCTION ABNORMAL 42 0.0011
708 AGEUSIA 28 0.0011
709 WEIGHT INCREASED 251 0.0011
710 WHITE BLOOD CELL COUNT INCREASED 43 0.0011
711 MADAROSIS 13 0.0011
712 HAEMOGLOBIN DECREASED 115 0.0011
713 EXPOSURE VIA SKIN CONTACT 29 0.0011
714 URTICARIA 187 0.0011
715 DYSARTHRIA 42 0.0011
716 THROAT IRRITATION 50 0.0011
717 FEELING COLD 31 0.0011
718 LIP SWELLING 37 0.0011
719 GASTROENTERITIS VIRAL 20 0.0011
720 FAECES DISCOLOURED 24 0.0011
721 LEUKOCYTOSIS 20 0.0011
722 MUSCLE ATROPHY 14 0.0011
723 MOOD ALTERED 30 0.0011
724 MUSCULOSKELETAL CHEST PAIN 17 0.0011
725 DEPRESSED MOOD 58 0.0011
726 DYSSTASIA 32 0.0011
727 NASOPHARYNGITIS 202 0.0011
728 INFLUENZA 122 0.0011
729 VISION BLURRED 150 0.0011
730 MUSCULOSKELETAL PAIN 57 0.0011
731 MOBILITY DECREASED 78 0.0011
732 ABNORMAL BEHAVIOUR 43 0.0011
733 MUSCLE TWITCHING 25 0.0011
734 ABDOMINAL PAIN 252 0.0011
735 EPISTAXIS 81 0.0011
736 CONFUSIONAL STATE 175 0.0011
737 SOMNOLENCE 218 0.0011
738 FLUID RETENTION 55 0.0011
739 BLOOD PRESSURE INCREASED 165 0.0011
740 TREATMENT NONCOMPLIANCE 59 0.0011
741 PALPITATIONS 126 0.0011
742 RESPIRATORY TRACT INFECTION 28 0.0011
743 DISEASE PROGRESSION 127 0.0011
744 DECREASED APPETITE 249 0.0011
745 MIDDLE INSOMNIA 20 0.0011
746 EMOTIONAL DISORDER 33 0.0011
747 HAEMORRHAGE INTRACRANIAL 16 0.0011
748 SNEEZING 24 0.0011
749 UPPER GASTROINTESTINAL HAEMORRHAGE 18 0.0011
750 BLOOD PRESSURE DECREASED 71 0.0011
751 SKIN CANCER 23 0.0011
752 THIRST 19 0.0011
753 TARDIVE DYSKINESIA 30 0.0011
754 PULMONARY CONGESTION 14 0.0011
755 MUSCULOSKELETAL STIFFNESS 93 0.0011
756 AMNESIA 69 0.0011
757 HEPATOCELLULAR INJURY 15 0.0011
758 HEART RATE DECREASED 37 0.0011
759 ABNORMAL DREAMS 29 0.0010
760 SPEECH DISORDER 55 0.0010
761 ABDOMINAL PAIN UPPER 216 0.0010
762 VISUAL IMPAIRMENT 130 0.0010
763 MEMORY IMPAIRMENT 144 0.0010
764 SYSTEMIC LUPUS ERYTHEMATOSUS 37 0.0010
765 DRUG PRESCRIBING ERROR 20 0.0010
766 DEMENTIA 29 0.0010
767 DISCOMFORT 63 0.0010
768 PULMONARY EMBOLISM 98 0.0010
769 RENAL DISORDER 48 0.0010
770 VOMITING 483 0.0010
771 NEUROTOXICITY 18 0.0010
772 GINGIVAL BLEEDING 14 0.0010
773 HYPOTENSION 205 0.0010
774 BLOOD GLUCOSE DECREASED 49 0.0010
775 ABDOMINAL DISCOMFORT 171 0.0010
776 CENTRAL NERVOUS SYSTEM LESION 14 0.0010
777 ENCEPHALOPATHY 25 0.0010
778 HEAD DISCOMFORT 18 0.0010
779 DRUG INTOLERANCE 98 0.0010
780 MYDRIASIS 13 0.0010
781 ANGINA PECTORIS 29 0.0010
782 RESTLESSNESS 37 0.0010
783 RESPIRATORY TRACT CONGESTION 16 0.0010
784 COLON CANCER 15 0.0010
785 HYPERHIDROSIS 129 0.0010
786 RESPIRATORY FAILURE 73 0.0010
787 BRADYCARDIA 53 0.0010
788 MOVEMENT DISORDER 32 0.0010
789 PERICARDIAL EFFUSION 23 0.0010
790 AGITATION 73 0.0010
791 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
792 MENTAL IMPAIRMENT 24 0.0010
793 POST PROCEDURAL COMPLICATION 19 0.0010
794 RASH MACULO-PAPULAR 22 0.0010
795 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23 0.0010
796 HERNIA 19 0.0010
797 BODY TEMPERATURE INCREASED 20 0.0010
798 RESPIRATORY DISTRESS 27 0.0010
799 LIVER INJURY 24 0.0010
800 DEVICE RELATED INFECTION 15 0.0010
801 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
802 LYMPHOMA 15 0.0010
803 AGRANULOCYTOSIS 18 0.0010
804 KIDNEY INFECTION 19 0.0010
805 THINKING ABNORMAL 18 0.0010
806 RASH GENERALISED 25 0.0010
807 FEBRILE NEUTROPENIA 64 0.0010
808 COLD SWEAT 17 0.0010
809 PSYCHOMOTOR HYPERACTIVITY 16 0.0010
810 APHASIA 29 0.0010
811 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
812 HYPONATRAEMIA 54 0.0010
813 BLOOD PRESSURE FLUCTUATION 23 0.0010
814 GASTROINTESTINAL HAEMORRHAGE 80 0.0010
815 CARDIO-RESPIRATORY ARREST 40 0.0010
816 ASCITES 28 0.0010
817 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
818 STEVENS-JOHNSON SYNDROME 21 0.0009
819 HEMIPARESIS 16 0.0009
820 BLOOD CREATINE PHOSPHOKINASE INCREASED 27 0.0009
821 INTENTIONAL PRODUCT USE ISSUE 82 0.0009
822 RESPIRATORY DISORDER 28 0.0009
823 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
824 NEUTROPHIL COUNT DECREASED 38 0.0009
825 APHONIA 13 0.0009
826 INCORRECT PRODUCT ADMINISTRATION DURATION 20 0.0009
827 LYMPHOPENIA 13 0.0009
828 PYREXIA 318 0.0009
829 MUCOSAL INFLAMMATION 24 0.0009
830 MANIA 15 0.0009
831 METASTASES TO LIVER 16 0.0009
832 TENDONITIS 14 0.0009
833 PRESCRIBED UNDERDOSE 18 0.0009
834 LUNG INFECTION 14 0.0009
835 COLITIS 34 0.0009
836 BLOOD URINE PRESENT 17 0.0009
837 HYPOKINESIA 13 0.0009
838 ACCIDENTAL EXPOSURE TO PRODUCT 92 0.0009
839 PANCREATITIS 47 0.0009
840 FEELING ABNORMAL 213 0.0009
841 HYPOACUSIS 38 0.0009
842 PANCYTOPENIA 49 0.0009
843 PLATELET COUNT DECREASED 93 0.0009
844 CHOKING 17 0.0009
845 HIP FRACTURE 28 0.0009
846 THROMBOSIS 70 0.0009
847 ABDOMINAL PAIN LOWER 22 0.0009
848 BLOOD GLUCOSE ABNORMAL 16 0.0009
849 NERVOUS SYSTEM DISORDER 27 0.0009
850 MELAENA 19 0.0009
851 CHILLS 101 0.0009
852 MALIGNANT NEOPLASM PROGRESSION 88 0.0009
853 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 61 0.0009
854 KNEE ARTHROPLASTY 18 0.0009
855 DISTURBANCE IN ATTENTION 46 0.0009
856 FREQUENT BOWEL MOVEMENTS 23 0.0009
857 BLINDNESS UNILATERAL 12 0.0008
858 ANAPHYLACTIC REACTION 47 0.0008
859 WHITE BLOOD CELL COUNT DECREASED 92 0.0008
860 FEELING HOT 52 0.0008
861 DYSGEUSIA 63 0.0008
862 ADVERSE EVENT 78 0.0008
863 HYPOCALCAEMIA 16 0.0008
864 FRACTURE 16 0.0008
865 PALLOR 23 0.0008
866 CARDIAC DISORDER 79 0.0008
867 PRODUCT ADMINISTRATION ERROR 17 0.0008
868 MUSCULOSKELETAL DISORDER 16 0.0008
869 PRODUCT PRESCRIBING ERROR 20 0.0008
870 FEELING JITTERY 16 0.0008
871 INJECTION SITE PRURITUS 56 0.0008
872 DELIRIUM 29 0.0008
873 PRURITUS GENERALISED 18 0.0008
874 FACE OEDEMA 14 0.0008
875 HOSPITALISATION 127 0.0008
876 MALAISE 362 0.0008
877 NEUTROPENIA 112 0.0008
878 INJECTION SITE SWELLING 63 0.0008
879 EPILEPSY 25 0.0008
880 METABOLIC ACIDOSIS 26 0.0008
881 NIGHTMARE 28 0.0008
882 PNEUMONITIS 22 0.0008
883 UPPER LIMB FRACTURE 16 0.0008
884 ARRHYTHMIA 38 0.0008
885 SPINAL FRACTURE 16 0.0008
886 IMPAIRED WORK ABILITY 17 0.0008
887 ACCIDENTAL OVERDOSE 29 0.0008
888 INJECTION SITE BRUISING 63 0.0008
889 BLOOD GLUCOSE INCREASED 148 0.0008
890 INJECTION SITE PAIN 239 0.0008
891 ILL-DEFINED DISORDER 47 0.0008
892 CRYING 28 0.0008
893 ANGER 26 0.0008
894 ANGIOEDEMA 34 0.0008
895 NERVOUSNESS 40 0.0008
896 ROAD TRAFFIC ACCIDENT 32 0.0008
897 THERAPY CESSATION 39 0.0008
898 PULMONARY OEDEMA 34 0.0008
899 CONVULSION 43 0.0008
900 CARDIAC ARREST 62 0.0008
901 HAEMATEMESIS 19 0.0007
902 LABORATORY TEST ABNORMAL 22 0.0007
903 LOCAL SWELLING 13 0.0007
904 MULTIPLE ORGAN DYSFUNCTION SYNDROME 21 0.0007
905 INJECTION SITE WARMTH 15 0.0007
906 INJECTION SITE ERYTHEMA 90 0.0007
907 INFUSION RELATED REACTION 48 0.0007
908 PRESCRIBED OVERDOSE 14 0.0007
909 CEREBROVASCULAR ACCIDENT 122 0.0007
910 IRRITABILITY 43 0.0007
911 WITHDRAWAL SYNDROME 30 0.0007
912 FEMUR FRACTURE 22 0.0007
913 DISORIENTATION 28 0.0007
914 FEAR 19 0.0007
915 GASTRIC DISORDER 24 0.0007
916 AGGRESSION 35 0.0007
917 HAEMORRHAGE 73 0.0007
918 INJECTION SITE URTICARIA 17 0.0007
919 INFLUENZA LIKE ILLNESS 57 0.0007
920 PLASMA CELL MYELOMA 27 0.0007
921 GENERAL PHYSICAL HEALTH DETERIORATION 80 0.0007
922 LOWER LIMB FRACTURE 13 0.0007
923 GLOSSODYNIA 15 0.0007
924 DRUG EFFECT DECREASED 36 0.0007
925 PANCREATITIS ACUTE 15 0.0007
926 FLUSHING 67 0.0007
927 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 132 0.0007
928 GYNAECOMASTIA 20 0.0006
929 EXTRAPYRAMIDAL DISORDER 16 0.0006
930 INTENTIONAL SELF-INJURY 13 0.0006
931 PSYCHOTIC DISORDER 19 0.0006
932 CEREBRAL HAEMORRHAGE 23 0.0006
933 INTERSTITIAL LUNG DISEASE 31 0.0006
934 PRODUCT QUALITY ISSUE 86 0.0006
935 PRODUCT PREPARATION ERROR 13 0.0006
936 ERUCTATION 12 0.0006
937 MATERNAL EXPOSURE DURING PREGNANCY 55 0.0006
938 PRODUCT AVAILABILITY ISSUE 14 0.0006
939 SEDATION 16 0.0006
940 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
941 MULTIPLE SCLEROSIS RELAPSE 41 0.0006
942 DISEASE RECURRENCE 28 0.0006
943 CARDIAC FAILURE 47 0.0006
944 DIABETIC KETOACIDOSIS 14 0.0006
945 INCORRECT DOSE ADMINISTERED 133 0.0006
946 COLITIS ULCERATIVE 26 0.0006
947 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 17 0.0006
948 MYOCARDIAL INFARCTION 101 0.0006
949 RHEUMATOID ARTHRITIS 64 0.0006
950 DRUG DOSE OMISSION 93 0.0006
951 INJECTION SITE RASH 17 0.0006
952 VAGINAL HAEMORRHAGE 24 0.0006
953 CARDIOVASCULAR DISORDER 14 0.0006
954 DRUG EFFECT INCOMPLETE 20 0.0006
955 UNDERDOSE 40 0.0005
956 EXPOSURE DURING PREGNANCY 34 0.0005
957 MULTIPLE SCLEROSIS 26 0.0005
958 INJECTION SITE REACTION 37 0.0005
959 LUNG NEOPLASM MALIGNANT 22 0.0005
960 ABASIA 13 0.0005
961 LACTIC ACIDOSIS 17 0.0005
962 DEATH 448 0.0005
963 NEOPLASM PROGRESSION 17 0.0005
964 PROSTATE CANCER 39 0.0005
965 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
966 NEOPLASM MALIGNANT 32 0.0005
967 SUICIDE ATTEMPT 29 0.0005
968 MOOD SWINGS 15 0.0005
969 ANAPHYLACTIC SHOCK 12 0.0005
970 INCORRECT DRUG ADMINISTRATION DURATION 13 0.0005
971 LOWER RESPIRATORY TRACT INFECTION 21 0.0005
972 INJECTION SITE MASS 17 0.0005
973 DEVICE ISSUE 41 0.0005
974 VISUAL ACUITY REDUCED 15 0.0005
975 EXTRA DOSE ADMINISTERED 18 0.0004
976 NO ADVERSE EVENT 79 0.0004
977 BLINDNESS 17 0.0004
978 PRODUCT SUBSTITUTION ISSUE 24 0.0004
979 DRUG ADMINISTRATION ERROR 12 0.0004
980 OVERDOSE 81 0.0004
981 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13 0.0004
982 DEVICE MALFUNCTION 25 0.0004
983 MEDICATION ERROR 19 0.0003
984 INJECTION SITE HAEMORRHAGE 27 0.0003
985 DEVICE LEAKAGE 12 0.0003
986 DEVICE DISLOCATION 12 0.0003
987 TOXICITY TO VARIOUS AGENTS 45 0.0003
988 PRODUCT STORAGE ERROR 21 0.0002
989 INTENTIONAL OVERDOSE 15 0.0002
990 BREAST CANCER 21 0.0002
991 DRUG WITHDRAWAL SYNDROME 19 0.0002
992 DRUG DEPENDENCE 29 0.0002